Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Return on Assets (2016 - 2025)

Fennec Pharmaceuticals (FENC) has disclosed Return on Assets for 15 consecutive years, with 0.14% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Assets fell 12.0% year-over-year to 0.14%, compared with a TTM value of 0.14% through Sep 2025, down 12.0%, and an annual FY2024 reading of 0.01%, up 58.0% over the prior year.
  • Return on Assets was 0.14% for Q3 2025 at Fennec Pharmaceuticals, up from 0.25% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.07% in Q1 2024 and bottomed at 1.01% in Q3 2023.
  • Average Return on Assets over 5 years is 0.48%, with a median of 0.58% recorded in 2022.
  • The sharpest move saw Return on Assets crashed -46bps in 2023, then soared 100bps in 2024.
  • Year by year, Return on Assets stood at 0.6% in 2021, then increased by 10bps to 0.54% in 2022, then fell by -24bps to 0.67% in 2023, then surged by 101bps to 0.0% in 2024, then plummeted by -4028bps to 0.14% in 2025.
  • Business Quant data shows Return on Assets for FENC at 0.14% in Q3 2025, 0.25% in Q2 2025, and 0.3% in Q1 2025.